Here’s what you need to know:
1. The two clinical trials included 243 patients, including 176 who received the implant.
2. The NUsurface implant is being tested on patients who have persistent knee pain after a meniscus surgery and have exhausted their treatment options. Patients who are too old for repair and too young for a total knee replacement are also included in the trials.
3. If approved by the FDA, the NUsurface will be the first artificial meniscus that does not require fixation to bone or soft tissues.
More articles on orthopedics and TJR:
3 orthopedic surgeons named in $950M kickback scheme, 2 plead guilty
DISC Sports & Spine Center creates minimally invasive spine surgery guide — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.